–
Prelude Therapeutics Inc
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−114
FY22:
−124
FY23:
−132
FY24:
−140
FY25:
−105
(positive)
Change from FY21 to FY25
millions USD
FY21:
−113
FY22:
−122
FY23:
−131
FY24:
−138
FY25:
−103
(positive)
Change from FY21 to FY25
millions USD
FY21:
−112
FY22:
−115
FY23:
−122
FY24:
−127
FY25:
−99.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−112
FY22:
−115
FY23:
−122
FY24:
−127
FY25:
−99.5
All amounts in millions USD